WallStSmart
MNPR

Monopar Therapeutics Inc

NASDAQ: MNPR · HEALTHCARE · BIOTECHNOLOGY

$52.15
+4.05% today

Updated 2026-04-30

Market cap
$361.51M
P/E ratio
P/S ratio
EPS (TTM)
$-1.85
Dividend yield
52W range
$28 – $105
Volume
0.2M

Monopar Therapeutics Inc (MNPR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-51.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+77.8%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+2.2%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+3.1%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-30$-0.61-19.1%$54.10$54.79+1.3%
2025-11-10$-0.48-20.3%$80.95$83.43+3.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.51$-0.61-19.1%
2025-09-30$-0.40$-0.48-20.3%
2025-06-30$-0.09$-0.35-288.9%
2025-03-31$-0.57$-0.38+32.9%
2024-12-31$-0.42$-2.75-554.8%
2024-09-30$-0.48$-0.37+22.9%
2024-06-30$-0.47$-0.50-6.4%
2024-03-31$-0.12$-0.10+16.7%
2023-12-31$-0.15$-0.12+20.0%
2023-09-30$-0.17$-0.14+17.6%
2023-06-30$-0.18$-0.16+11.1%
2023-03-31$-0.22$-0.19+13.6%

Frequently asked questions

Has Monopar Therapeutics Inc beaten earnings estimates?
Monopar Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -51.6% over the last 4 quarters.
How does MNPR stock react to earnings?
MNPR stock has moved an average of +2.2% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.